These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23686162)

  • 1. Leydig cell tumor in an anabolic steroid abuser.
    Belli S; Guidi A; Simoni M; Carani C; Granata AR
    J Endocrinol Invest; 2013 Nov; 36(10):913. PubMed ID: 23686162
    [No Abstract]   [Full Text] [Related]  

  • 2. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
    Chimento A; Sirianni R; Zolea F; De Luca A; Lanzino M; Catalano S; Andò S; Pezzi V
    J Cell Physiol; 2012 May; 227(5):2079-88. PubMed ID: 21769864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of testicular interstitial cell tumors of the albino rat using cadmium chloride].
    Knorre D
    Arch Geschwulstforsch; 1971; 38(3):257-63. PubMed ID: 5144206
    [No Abstract]   [Full Text] [Related]  

  • 4. Giant hepatic adenoma associated with anabolic-androgenic steroid abuse: case report.
    Pais-Costa SR; Lima OA; Soares AF
    Arq Bras Cir Dig; 2012; 25(3):180-2. PubMed ID: 23411809
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone excretion in cadmium chloride induced testicular tumours in rats.
    Favino A; Cavalleri A; Nazari G; Tilli M
    Med Lav; 1968 Jan; 59(1):36-40. PubMed ID: 5740981
    [No Abstract]   [Full Text] [Related]  

  • 6. Cadmium-induced Leydig cell tumors of rat testis: morphologic and cytochemical study.
    Reddy J; Svoboda D; Azarnoff D; Dawar R
    J Natl Cancer Inst; 1973 Sep; 51(3):891-903. PubMed ID: 4743560
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatology: hepatocellular carcinoma in a young man secondary to androgenic anabolic steroid abuse.
    Kesler T; Sandhu RS; Krishnamoorthy S
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1852. PubMed ID: 25392920
    [No Abstract]   [Full Text] [Related]  

  • 8. Caution for anabolic androgenic steroid use: a case report of multiple organ dysfunction syndrome.
    Unai S; Miessau J; Karbowski P; Baram M; Cavarocchi NC; Hirose H
    Respir Care; 2013 Dec; 58(12):e159-63. PubMed ID: 23611866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steroids are a growing problem at gyms].
    Rane A; Rosén T; Skårberg K; Heine L; Ljungdahl S
    Lakartidningen; 2013 Sep 25-Oct 8; 110(39-40):1741-6. PubMed ID: 24245430
    [No Abstract]   [Full Text] [Related]  

  • 10. Complexities in clarifying the diagnostic criteria for anabolic-androgenic steroid dependence.
    Scally MC; Tan RS
    Am J Psychiatry; 2009 Oct; 166(10):1187; author reply 1188. PubMed ID: 19797448
    [No Abstract]   [Full Text] [Related]  

  • 11. Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians.
    Kanayama G; Hudson JI; Pope HG
    Psychother Psychosom; 2020; 89(2):65-73. PubMed ID: 32066136
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of Leydig cell tumour in association with clomiphene treatment for oligozoospermia.
    Bujan L; Mieusset R; De Zong Z; Mansat A; Pontonnier F
    Br J Urol; 1992 Jun; 69(6):659-60. PubMed ID: 1638354
    [No Abstract]   [Full Text] [Related]  

  • 13. Leydig cell tumor of the testis. Morphological and endocrinological investigations in two cases.
    Mikuz G; Schwarz S; Höpfel-Kreiner I; Greber F
    Eur Urol; 1980; 6(5):293-300. PubMed ID: 7398702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a dopamine agonist on the development of Leydig cell hyperplasia in Sprague-Dawley rats.
    Dirami G; Teerds KJ; Cooke BA
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):169-77. PubMed ID: 8917689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of anabolic-androgenic steroids by athletes.
    Goldberg L; Bosworth E; Elliot D; Bents R
    N Engl J Med; 1990 Mar; 322(11):775-6. PubMed ID: 2308608
    [No Abstract]   [Full Text] [Related]  

  • 16. Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism.
    Prahalada S; Majka JA; Soper KA; Nett TM; Bagdon WJ; Peter CP; Burek JD; MacDonald JS; van Zwieten MJ
    Fundam Appl Toxicol; 1994 Feb; 22(2):211-9. PubMed ID: 8005373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leydig cell tumor in patient on estrogen therapy.
    Deshmukh AS; Hartung WH
    Urology; 1983 May; 21(5):538-9. PubMed ID: 6857903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.
    Boyadjiev NP; Georgieva KN; Massaldjieva RI; Gueorguiev SI
    J Sports Med Phys Fitness; 2000 Sep; 40(3):271-4. PubMed ID: 11125771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse.
    Huseby RA
    Cancer Res; 1980 Apr; 40(4):1006-13. PubMed ID: 7357531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic androgenic steroid-induced Takotsubo cardiomyopathy.
    Placci A; Sella G; Bellanti G; Margheri M
    BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25804946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.